Showing 36,902 results

Filters
PrEP

Australia: PrEP listing decision deferred

Editor's pick
Australian Journal of Pharmacy
21 August 2017
PrEP

How PrEP changed Matt's life

Editor's pick
BBC (video)
21 August 2017
PrEP

PrEP impact trial questions and answers

Editor's pick
NHS England
21 August 2017
Changing treatment

Terrence Higgins Trust and BHIVA advise on the use of generic HIV antiretroviral therapy

Editor's pick
Terrence Higgins Trust
16 August 2017
Harm reduction

Scotland May Now Have Highest Rate of Drug-Related Deaths in the EU

Editor's pick
Talking Drugs
16 August 2017
HIV testing policies & guidelines

Zambian President announces compulsory HIV testing

Editor's pick
CGTN Africa
16 August 2017
The search for a cure

Understanding Exactly How the ‘Berlin Patient’ Was Cured

Editor's pick
amfAR
16 August 2017
Harm reduction

What Trump's National Opioid Emergency Should Look Like

Editor's pick
Vice
15 August 2017
Pharmaceutical industry

Gilead's Newer Tenofovir Patents

Editor's pick
Seeking Alpha
15 August 2017
HIV testing programmes & uptake

Gay sauna fights HIV in Britain with first-of-its-kind test vending machine

Editor's pick
Reuters
14 August 2017
Pharmaceutical industry

AbbVie Mavyret Price Threatens Gilead Hepatitis Dominance

Editor's pick
Bloomberg
7 August 2017
Pharmaceutical industry

Mylan to Provide Generic Truvada for U.K. Trial

Editor's pick
Wall Street Journal
3 August 2017
PrEP

Controversial PrEP study from NHS England due to start in September

Editor's pick
HIV i-Base
3 August 2017
Experiences of stigma

Insurer Denies Truvada Due to ‘High Risk Homosexual Behavior’

Editor's pick
My Fabulous Disease
3 August 2017
PrEP

NHS England announces world’s largest single PrEP implementation trial to prevent HIV infection

Editor's pick
NHS England
3 August 2017
Exposure to HIV through medical procedures

To tackle the contaminated blood scandal, Britain must learn from Canada

Editor's pick
The Guardian
2 August 2017
Hepatitis C treatment

Direct-acting antivirals successfully treating hepatitis C, says Public Health England

Editor's pick
Pharmaceutical Journal
2 August 2017
Resistance

A massive second global wave of AIDS is coming — perhaps within the next 10 years

Editor's pick
Business Insider
31 July 2017
New & experimental hepatitis C treatment

European Commission Grants AbbVie's MAVIRET® (glecaprevir/pibrentasvir) Marketing Authorization for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)

Editor's pick
AbbVie press release
31 July 2017
New & experimental hepatitis C treatment

European Commission Grants Marketing Authorization for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Genotypes of Chronic Hepatitis C

Editor's pick
Gilead press release
31 July 2017
Chemsex & recreational drug use

Don’t Believe the Hype: The New Drugs Strategy Ignores the LGBT Community

Editor's pick
Vice
29 July 2017
Hepatitis C treatment

From chronic to cured: could Australia be the first country in the world to eliminate hep C?

Editor's pick
Kirby Institute
28 July 2017
PrEP

Philippines trials anti-HIV drug as cases hit record high

Editor's pick
Thomson Reuters
27 July 2017
Global health targets

HIV treatment: Strategies to reach the next 10 million patients

Editor's pick
Devex
27 July 2017